Advanced Education Certification Series: Opioids
Over the last decade, healthcare providers (HCPs) have been on the frontlines regarding the use of opioid analgesics to manage chronic pain. Opinions continue to flourish, with many professionals gravitating to one extreme or another, either utilizing opioids too much, too little, or in some cases not all. HCPs face medical decisions every day revolving around prescription opioid medication utilization. However, so few are armed with the education to make those decisions based on best practices, and thus do not have confidence in transcending the plethora of published guidelines. The need for opioid education has grown in relation to the increased scrutiny of treatment decisions by insurance companies and regulatory agencies. To address this need, PAINWeek has created the Advanced Education Opioids Certification Series to enable practitioners to successfully treat their chronic pain patients with a full understanding of the risks and benefits of this class of analgesics.
This certification comprises 15 CE/CME hours of modules with self-assessment quizzes, PLUS a bonus 4 hours composed of three segments: 1) summaries of key learnings, 2) case studies, and 3) faculty panel discussion.
Upon registration, you will receive instructions and reminder emails for logging in and other pertinent details related to the program. Please note that these 15 modules, and their evaluations, and the bonus 4 hours, must be completed in order to take your final 100 question exam. Then you will receive your final certificate.
The educational design of this activity addresses the needs of frontline practitioners involved in the treatment of patients with chronic pain.
After completing this activity, the participant should be better able to:
- Describe the foundational concepts and background of opioidology, opioid therapy, dosing, opioid use disorder, and opioid formulations
- Discuss clinical pearls for opioids, including side effects and drug interactions
- Review epidemiology of opioid addiction and distinguish between abuse, misuse, diversion, and addiction
- Describe clinical pearls regarding 21st century drug testing
- Explain considerations healthcare providers should take into account when identifying the role of an abuse-deterrent opioid in a patient’s pain management regimen
- Assess when to recommend use of an abuse-deterrent opioid in patient care
- Differentiate between tolerance, psychological dependence, physical dependence, and opioid use disorder
- Distinguish between available therapies to treat opioid use disorder, including behavioral therapy, and their mechanisms for treating opioid addiction
This activity is provided by Global Education Group.
Meet the Faculty
Douglas L. Gourlay
MD, MSc, FRCPC, DFASAM
Doug Gourlay trained as a physical chemist and anesthesiologist, focusing his practice on the assessment and treatment of chronic pain patients suffering from concurrent substance use disorders. He has written extensively on the subject of Pain and Addiction, especially in the realm of drug testing and monitoring.
PharmD, MBA, BCGP, CPE
Mark Garofoli, PharmD, MBA, BCGP, CPE is a Clinical Pain Management Pharmacist at the WVU Medicine Center for Integrative Pain Management, a faculty member in the WVU School of Medicine Pain Fellowship Program, and a Clinical Assistant Professor and Director of Experiential Learning for the West Virginia University (WVU) School of Pharmacy (SoP). Dr. Garofoli received his PharmD at the University of Pittsburgh SoP in 2004 and his MBA from Strayer University in 2008. He is board certified in Geriatric Care (BGCP) along with being a certified pain educator (CPE) and certified tobacco treatment specialist (CTTS). Dr. Garofoli began his career with CVS Health in community pharmacy management, then worked as a Humana Healthcare MTM clinical pharmacist, leading to the development of patient-centered and managed care centered programs and the Safe & Effective Management of Pain West Virginia guidelines. Mark has consulted as a CDC grant reviewer, a professional journals reviewer, a civil and criminal expert witness, and is the host of the “PAIN POD” on the Pharmacy Podcast Network with an international audience of 80,000 healthcare professionals. Mark’s professional passions lie within pain management and addiction patient care and education for healthcare professionals and society alike, in essence, trying to make a difference.
Mary Lynn McPherson
PharmD, MA, MDE, BCPS, CPE
Mary Lynn McPherson, PharmD, MA, MDE, BCPS, is Professor and Executive Director, Advanced Post-Graduate Education in Palliative Care in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy in Baltimore. In addition to a PharmD degree, Dr. McPherson has a master’s degree in Instructional Systems Development, and a Masters in Distance Education and e-Learning. Dr. McPherson has maintained a practice in both hospice (local and national) and ambulatory care her entire career. She is the Executive Program Director of the Online Doctor of Philosophy, Master of Science and Graduate Certificate Program in Palliative Care at the University of Maryland, Baltimore. Dr. McPherson is particularly interested in the safe and effective use of medications in patients with a life-limiting illness, ranging from drug selection, deprescribing, and risk mitigation.
Dr. McPherson developed one of the first and few palliative care pharmacy residencies in the U.S. Dr. McPherson has won numerous awards for teaching, and her innovative practice in end of life care. She has published numerous articles, chapters, and four books including the second edition of the best-selling “Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing.
Alexandra L. McPherson,
Alexandra McPherson, PharmD, MPH, is a Palliative Care Clinical Pharmacy Specialist at the MedStar Washington Hospital Center in DC.
Tanya J. Uritsky
Tanya Uritsky, PharmD, CPE is the Opioid Stewardship Coordinator at the Hospital of the University of Pennsylvania and was a founding member of the Palliative Care Service. She is Co-Chair of the Penn Medicine Opioid Task Force and also the Chair of the Society of Pain and Palliative Care’s Opioid Stewardship Taskforce. She was awarded Palliative Care Practitioner of the Year by PAINWeek in 2015 and received the 2020 Pennsylvania Society of Health-System Pharmacists Joe E. Smith Award for excellence in practice and service to the community and pharmacy profession.
Thomas B. Gregory
PharmD, BCPS, FASPE
Thomas B Gregory, Pharm.D., BCPS, CPE, FASPE is a clinical pharmacy specialist in pain and palliative care as well as emergency medicine. Dr. Gregory has been active providing care to patients in pain since his residency and throughout his career. He received the clinical pain educator of the year award from the American society of pain educators in 2010 and a fellow in 2016. Dr. Gregory has been an active participant in the literature surrounding pain management in addition to serving as an editorial board member and review for multiple pain and pharmacy related journals. Dr. Gregory works with learners in multiple disciplines and stages of their formal and post graduate education. Dr. Gregory has areas of practice interest including sickle cell disease, palliative care and critical care analgesia and sedation.
Timothy J. Atkinson,
PharmD, BCPS, CPE
Timothy J Atkinson, PharmD, BCPS, CPE is a Clinical Pharmacy Practitioner in Pain Management at the Veterans Affairs (VA) Tennessee Valley Healthcare System (TVHS). Dr. Atkinson specializes in high-risk chronic pain management and comorbid OUD and pain and his practice has won national awards for innovation and excellence. Dr. Atkinson is passionate about training the next generation of pain pharmacists and is the Director for the PGY2 Pain Management & Palliative Care Residency Program at TVHS. Dr. Atkinson engages in several roles nationally within VA to represent and promote pain pharmacy activities including: The Clinical Pharmacy Practice Office (CPPO) Pain Subject Matter Expert Workgroup, Chair of the VHA Pharmacy Residency Practice Office (PRPO) Pain Residency Program Director Subgroup, and he represents pain on the VA National PRPO Pharmacy Residency Advisory Board. In these roles, Dr. Atkinson has successfully secured two large pain residency expansions across the United States allowing VA to train the majority of pharmacy pain specialists each year. Dr. Atkinson contributes to the literature often and serves as peer reviewer for several journals and as Section Editor for opioids and substance use for the Journal of Pain Research.
PharmD, DAAPM, FCCP, FASHP
Dr. Fudin graduated from Albany College of Pharmacy & Health Sciences with his Bachelors Degree and Pharm.D. He completed an Oncology/Hematology fellowship at SUNY/Upstate Medical Center. He is a Diplomate to the Academy of Integrative Pain Management and a Fellow to the American College of Clinical Pharmacy, the American Society of Health-system Pharmacists, and the Federation of State Medical Board.
Dr. Fudin is a Senior Section Editor for Pain Medicine, Co-Editor-At-Large for Practical Pain Management, Senior Editor for Pain Medicine, and peer reviewer for several professional medical and pharmacy journals. He has participated in developing practice guidelines for use of opioids in chronic noncancer pain and participated in national (US Health and Human Services) and international guideline development for various pain types.
In 2011, he established a Pharmacy Pain Residency Program at the Stratton Veterans Administration Medical Center in Albany NY and was Program Director through 2020. He holds adjunct faculty appointments at several colleges of pharmacy and has been an invited speaker on pain therapeutics nationally and internationally.
He is owner and managing editor for paindr.com and President of Remitigate Therapeutics offering virtual telemedicine pain consultations. He is also the Founder/President of Remitigate, LLC, a software development company that has provided platforms which aid clinicians to enhance opioid safety regarding urine drug screen interpretation and predictability of opioid-induced respiratory depression.
In addition to several guest Podcasts, he is a prolific lecturer, writer with over 350 publications, and researcher on pain management topics.
Mel Pohl, MD, DFASAM is a Family Practitioner. He is the Senior Medical Consultant of the Pain Recovery Program at The Pointe Malibu Recovery Center. He is certified by the American Board of Addiction Medicine (ABAM) and is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Nevada School of Medicine.
He is the author of A Day without Pain, revised edition (Central Recovery Press, 2011) and The Pain Antidote - Stop Suffering from Chronic Pain, Avoid Addiction to Painkillers, and Reclaim Your Life (DaCapo, 2015). Dr. Pohl filmed a show for PBS on chronic pain which aired around the country in 2016.
Ravi Prasad, PhD is a psychologist by training and currently Clinical Professor and Director of Behavioral Health in the Department of Anesthesiology and Pain Medicine at the University of California, Davis School of Medicine. His clinical work focuses primarily on the evaluation and treatment of individuals suffering from acute and chronic pain conditions. He is actively engaged in leadership activities at regional and national levels through which he has been involved with interprofessional core competency, curriculum, and program development; lobbying efforts to change policies related to psychological care; and translation of research innovations into clinical practice. Outside the realm of pain, he has an avid interest in clinician wellness and has led efforts to implement associated initiatives in healthcare settings
Brett B. Snodgrass
NP, FNP-C, CPE, FACCP, FAANP
Ravi Prasad, PhD is a psychologist by training and currently Clinical Professor and Director of Behavioral Health in the Department of Anesthesiology and Pain Medicine at the University of California, Davis School of Medicine. His clinical work focuses primarily on evaluation and treatment of individuals suffering from acute and chronic pain conditions. He is actively engaged in leadership activities at regional and national levels through which he has been involved with interprofessional core competency, curriculum, and program development; lobbying efforts to change policies related to psychological care; and translation of research innovations into clinical practice. Outside the realm of pain, he has an avid interest in clinician wellness and has led efforts to implement associated initiatives in healthcare settings
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter
Reported Financial Relationship
Timothy J. Atkinson, PharmD, BCPS, CPE
Consulting Fee: Purdue Pharma LP
Jeffrey Fudin, PharmD, FCCP, FASHP, FFSMB
Consulting Fee: AcelRx Pharmaceuticals, BioDelivery Sciences International, GlaxoSmithKline (GSK), Hisamitsu America Inc, Hikma Pharmaceuticals, Salix Pharmaceuticals
Honoraria: AcelRx Pharmaceuticals, general consulting, BioDelivery Sciences International, general consulting, Scilex Pharmaceuticals, Collaborative non-paid publications
Speakers Bureau: AcelRx Pharmaceuticals, Salix Pharmaceuticals
Other: Abbott Laboratories, Lecture, non-speakers’ bureau;
Mark P. Garofoli, PharmD, MBA, BCGP, CPE, CTTS
Consulting Fee: HealthXL, Speranza
Other: Expert Witness—Cardinal Health
Thomas B. Gregory, Pharm.D., BCPS, CPE, FASPE
Douglas Gourlay, MD, MSC, FRPC, DFASAM
Alexandra L. McPherson, PharmD, MPH
Mary Lynn McPherson, PharmD, MA, MDE, BCPS
Mel Pohl, MD
Ravi Prasad, PhD
Brett B. Snodgrass, FNP-C, CPE, FACPP, FAANP
Speakers Bureau: Salix Pharmaceuticals
Tanya J. Uritsky, PharmD
Consulting Fee: AcelRx
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Planner or Manager
Reported Financial Relationship
Rhys Williams, MSN, FNP-C, RN
Nothing to disclose
Kristin Delisi, NP
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 15.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.25 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 15.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Global Education Group designates this continuing education activity for 15.25 contact hour(s) (1.525 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-0000-21-300-H01-P)
This is a knowledge-based activity.
Psychology Accreditation Statement
Global Education Group (Global) is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Global maintains responsibility for this program and its content.
This activity has been approved for a maximum of 15.0 CE credits for psychologists. The instructional level of this activity is intermediate.
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 15.25 contact hour(s) (which includes 7.3 hour(s) of pharmacology).
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15.25 hours of Category 1 credit for completing this program.
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
Instructions to Receive Credit
During the period from November 12, 2021, to november 12, 2022 , participants must complete the activity evaluation and obtain a score of 75% or better on the posttest and on the final comprehensive examination. Upon completion, your certificate will be available to print. For questions about receiving certificates, please contact firstname.lastname@example.org.
For Pharmacists: Please complete the evaluation instructions above. You must complete the activity in its entirety. Partial credit cannot be awarded. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks of completing this activity.
Fee & Refund/Cancellation Policy
Cancellations must be submitted in writing. For verification, if you are calling to cancel, we will still require you to send an email to email@example.com with your intent to cancel. You will receive confirmation of your cancellation via email. Cancellations received:
- Within 24 hours of registration are fully refundable
- More than 60 days minus $100 administrative fee
- 15.25 AANP
- 15.25 ACCME (All Other)
- 15.25 ACCME (MD/DO Only)
- 15.25 ACPE Pharmacy
- 15.25 ANCC
- 15.00 APA
1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
512 MB of RAM (1 GB recommended)
Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)
1.83 GHz Intel Core Duo or faster processor
512 MB of RAM (1 GB recommended)
MAC OS X 10.12, 10.13 and 10.14
Mozilla Firefox, Apple Safari, Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)